{
  "resourceType": "Condition",
  "id": "85ff5d11-568b-4399-aade-a13c3bfaf833",
  "meta": {
    "versionId": "1",
    "lastUpdated": "2025-12-09T02:17:17.474663Z",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/Condition"
    ]
  },
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Siddha Diagnosis:</b> ABA1.1 - Vaḷi Mañcaḷ Nōy</p><p><b>ICD-11 Standard:</b> 2528 - ICD-11 MMS – 01/2023</p><p><b>ICD-11 TM2:</b> SK63 - Day blindness disorder (TM2)</p></div>"
  },
  "clinicalStatus": {
    "coding": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/condition-clinical",
        "code": "active",
        "display": "Active"
      }
    ]
  },
  "verificationStatus": {
    "coding": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/condition-ver-status",
        "code": "confirmed",
        "display": "Confirmed"
      }
    ]
  },
  "category": [
    {
      "coding": [
        {
          "system": "http://terminology.hl7.org/CodeSystem/condition-category",
          "code": "encounter-diagnosis",
          "display": "Encounter Diagnosis"
        }
      ]
    }
  ],
  "code": {
    "coding": [
      {
        "system": "http://who.int/icd/tm2/siddha",
        "code": "ABA1.1",
        "display": "Vaḷi Mañcaḷ Nōy"
      },
      {
        "system": "http://id.who.int/icd/release/11/mms",
        "code": "2528",
        "display": "ICD-11 MMS – 01/2023",
        "extension": [
          {
            "url": "http://hl7.org/fhir/StructureDefinition/data-absent-reason",
            "valueCode": "mapped"
          },
          {
            "url": "http://example.org/fhir/StructureDefinition/mapping-confidence",
            "valueDecimal": 0.8448
          }
        ]
      },
      {
        "system": "http://id.who.int/icd/release/11/tm2",
        "code": "SK63",
        "display": "Day blindness disorder (TM2)",
        "extension": [
          {
            "url": "http://hl7.org/fhir/StructureDefinition/data-absent-reason",
            "valueCode": "mapped"
          },
          {
            "url": "http://example.org/fhir/StructureDefinition/mapping-confidence",
            "valueDecimal": 0.8372
          }
        ]
      }
    ],
    "text": "Vaḷi Mañcaḷ Nōy"
  },
  "subject": {
    "reference": "Patient/sdf23",
    "display": "Patient"
  },
  "recordedDate": "2025-12-09T02:17:17.474663Z",
  "encounter": {
    "reference": "Encounter/221r3"
  },
  "recorder": {
    "reference": "Practitioner/3wfefew3",
    "display": "Practitioner"
  },
  "evidence": [
    {
      "code": [
        {
          "coding": [
            {
              "system": "http://id.who.int/icd/release/11/mms",
              "code": "2528",
              "display": "ICD-11 MMS – 01/2023"
            }
          ],
          "text": "ICD-11 Standard mapping (confidence: 0.8448)"
        }
      ]
    },
    {
      "code": [
        {
          "coding": [
            {
              "system": "http://id.who.int/icd/release/11/tm2",
              "code": "SK63",
              "display": "Day blindness disorder (TM2)"
            }
          ],
          "text": "ICD-11 TM2 mapping (confidence: 0.8372)"
        }
      ]
    }
  ],
  "note": [
    {
      "text": "ICD-11 Standard Definition: XM9XF5 Tribromacetaldehyde XM1DU6 Trichloroethanol XM4236 Trichloroethyl phosphate XM68E8 Triclofos XM2334 Trional XM16S3 Triple bromides XM3PP3 Valerian root XM0MV0 Valerian tincture XM1WZ4 Valmid XM2TP4 Valnoctamide XM2AQ9 Welldorm XM1ZF1 Buspirone XM01J5 Mephenoxalone XM9TL2 Propiomazine XM15N4 Sodium oxybate XM3EH5 Benzoctamine XM9727 Gedocarnil XM5928 Fabomotizole XM4DF5 Lavandulae aetheroleum XM8488 Valerianae radix XM2HN6 Suvorexant XM2AY7 Dipiperonylaminoethanol XM9235 Lemborexant XM1VL2 Hexethal (sodium) XM7MG1 Mephebarbital XM0217 Methitural XM2XY6 4-Aminobutyric acid ICD-11 MMS – 01/2023 2529 Other and unspecified drugs, medicaments and biological substances Antidotes"
    },
    {
      "text": "ICD-11 TM2 Definition: \"Loss of vision during day time. (AYU) vitated pitta affecting the vision (SID) It is explained by increased Vaḷi (Vayu for intellectual functions and Vayu for ophthalmic function), Aẕal (Aẕal for vision) and Aiyam (Aiyam for strengthening sense organs). Among the seven physical constituents Cāram, Cennīr, Ūṉ gets affected (UNA) dissolution of optic Rūḥ and humours of eyes in sunlight\""
    }
  ]
}